Upgrade to SI Premium - Free Trial

Acadia Pharmaceuticals (ACAD) PT Raised to $37 at RBC Capital on 'Strong Sales'

August 5, 2026 7:44 AM
(Updated - August 5, 2026 9:16 AM EDT)

RBC Capital analyst Brian Abrahams raised the price target on Acadia ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change